CS First Boston Boosts Target on AmeriSource Health

Analyst Robert Willoughby likes the drug distributor's merger with Bergen Brunswig

CS First Boston raised the target and reiterates buy on AmeriSource Health (AAS ).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.